{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T13:01:25Z","timestamp":1791118885618,"version":"4.1.0"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,8,9]],"date-time":"2011-08-09T00:00:00Z","timestamp":1312848000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1007\/s00109-011-0801-z","type":"journal-article","created":{"date-parts":[[2011,8,8]],"date-time":"2011-08-08T11:32:51Z","timestamp":1312803171000},"page":"5-13","source":"Crossref","is-referenced-by-count":68,"title":["Molecular mechanisms underlying cardiac antihypertrophic and antifibrotic effects of natriuretic peptides"],"prefix":"10.1007","volume":"90","author":[{"given":"Camilla","family":"Calvieri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Speranza","family":"Rubattu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Volpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,8,9]]},"reference":[{"key":"801_CR1","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2478\/s11658-007-0046-6","volume":"13","author":"M Piechota","year":"2008","unstructured":"Piechota M, Banach M, Jacon A, Rysz J (2008) Natriuretic peptides in cardiovascular diseases. Cell Mol Biol Lett 13:155\u2013181","journal-title":"Cell Mol Biol Lett"},{"key":"801_CR2","doi-asserted-by":"crossref","unstructured":"Battistoni A, Rubattu S, Volpe M. (2011) Circulating biomarkers with preventive, diagnostic and prognostic implications in cardiovascular diseases. Int J Cardiol","DOI":"10.1016\/j.ijcard.2011.06.066"},{"key":"801_CR3","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1067\/mhj.2001.117131","volume":"142","author":"W Qi","year":"2001","unstructured":"Qi W, Mathisen P, Kjekshus J, Simonsen S, Bjornerheim R, Endresen K, Hall C (2001) Natriuretic peptides in patients with aortic stenosis. Am Heart J 142:725\u2013732","journal-title":"Am Heart J"},{"key":"801_CR4","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1161\/01.HYP.28.1.22","volume":"28","author":"T Nishikimi","year":"1996","unstructured":"Nishikimi T, Yoshihara F, Morimoto A, Ishikawa K, Ishimitsu T, Saito Y, Kangawa K, Matsuo H, Omae T, Matsuoka H (1996) Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension. Hypertension 28:22\u201330","journal-title":"Hypertension"},{"key":"801_CR5","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1097\/HJH.0b013e3282435b1e","volume":"25","author":"S Cavallero","year":"2007","unstructured":"Cavallero S, Gonz\u00e1lez GE, Puy\u00f3 AM, Ros\u00f3n MI, P\u00e9rez S, Morales C, Hertig CM, Gelpi RJ, Fern\u00e1ndez BE (2007) Atrial natriuretic peptide behaviour and myocyte hypertrophic profile in combined pressure and volume-induced cardiac hypertrophy. J Hypertens 25:1940\u20131950","journal-title":"J Hypertens"},{"key":"801_CR6","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/ajh.2008.174","volume":"21","author":"S Rubattu","year":"2008","unstructured":"Rubattu S, Sciarretta S, Valenti V, Stanzione R, Volpe M (2008) Natriuretic peptides: an update on bioactivity, potential therapeutic use and implication in cardiovascular diseases. Am J Hypertens 21:733\u2013741","journal-title":"Am J Hypertens"},{"key":"801_CR7","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1677\/jme.1.02138","volume":"38","author":"LJ Ellmers","year":"2007","unstructured":"Ellmers LJ, Scott NJ, Piuhola J, Maeda N, Smithies O, Frampton CM, Richards AM, Cameron VA (2007) Npr1-regulated gene pathways contributing to cardiac hypertrophy and fibrosis. J Mol Endocrinol 38:245\u2013257","journal-title":"J Mol Endocrinol"},{"key":"801_CR8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2174\/157340309787048068","volume":"5","author":"I Kishimoto","year":"2009","unstructured":"Kishimoto I, Tokudome T, Horio T, Garbers DL, Nakao K, Kangawa K (2009) Natriuretic peptide signaling via guanylyl cyclase (GC)-A: an endogenous protective mechanism of the heart. Curr Cardiol Rev 5:45\u201351","journal-title":"Curr Cardiol Rev"},{"key":"801_CR9","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1073\/pnas.051625598","volume":"98","author":"I Kishimoto","year":"2001","unstructured":"Kishimoto I, Rossi K, Garbers DL (2001) A genetic model provides evidence that the receptor for atrial natriuretic peptide (guanylyl cyclase-A) inhibits cardiac ventricular myocyte hypertrophy. Proc Natl Acad Sci U S A 98:2703\u20132706","journal-title":"Proc Natl Acad Sci U S A"},{"key":"801_CR10","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1172\/JCI17061","volume":"111","author":"R Holtwick","year":"2003","unstructured":"Holtwick R, van Eickels M, Skryabin BV, Baba HA, Bubikat A, Begrow F, Schneider MD, Garbers DL, Kuhn M (2003) Pressure-independent cardiac hypertrophy in mice with cardiomyocyte-restricted inactivation of the atrial natriuretic peptide receptor guanylyl cyclase-A. J Clin Invest 111:1399\u20131407","journal-title":"J Clin Invest"},{"key":"801_CR11","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1172\/JCI11273","volume":"107","author":"JW Knowles","year":"2001","unstructured":"Knowles JW, Esposito G, Mao L, Hagaman JR, Fox JE, Smithies O, Rockman HA, Maeda N (2001) Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A-deficient mice. J Clin Invest 107:975\u2013984","journal-title":"J Clin Invest"},{"key":"801_CR12","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0008-6363(02)00667-3","volume":"57","author":"AC Rosenkranz","year":"2003","unstructured":"Rosenkranz AC, Woods RL, Dusting GJ, Ritchie RH (2003) Antihypertrophic actions of the natriuretic peptides in adult rat cardiomyocytes: importance of cyclic GMP. Cardiovasc Res 57:515\u2013522","journal-title":"Cardiovasc Res"},{"key":"801_CR13","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jacc.2005.12.081","volume":"48","author":"S Rubattu","year":"2006","unstructured":"Rubattu S, Bigatti G, Evangelista A, Lanzani C, Stanzione R, Zagato L, Manunta P, Marchitti S, Venturelli V, Bianchi G et al (2006) Association of atrial natriuretic peptide and type a natriuretic peptide receptor gene polymorphisms with left ventricular mass in human essential hypertension. J Am Coll Cardiol 48:499\u2013505","journal-title":"J Am Coll Cardiol"},{"key":"801_CR14","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1097\/HJH.0b013e32803cae3c","volume":"25","author":"S Rubattu","year":"2007","unstructured":"Rubattu S, Sciarretta S, Ciavarella GM, Venturelli V, De Paolis P, Tocci G, De Biase L, Ferrucci A, Volpe M (2007) Reduced levels of pro-atrial natriuretic peptide in hypertensive patients with metabolic syndrome and their relationship with LVH. J Hypertens 25:833\u2013839","journal-title":"J Hypertens"},{"key":"801_CR15","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1161\/01.RES.0000117070.86556.9F","volume":"94","author":"AM Kapoun","year":"2004","unstructured":"Kapoun AM, Liang F, O'Young G, Damm DL, Quon D, White RT, Munson K, Lam A, Schreiner GF, Protter AA (2004) B-type natriuretic peptide exerts broad functional opposition to transforming growth factor-beta in primary human cardiac fibroblasts: fibrosis, myofibroblast conversion, proliferation, and inflammation. Circ Res 94:453\u2013461","journal-title":"Circ Res"},{"key":"801_CR16","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.1073\/pnas.070371497","volume":"97","author":"N Tamura","year":"2000","unstructured":"Tamura N, Ogawa Y, Chusho H, Nakamura K, Nakao K, Suda M, Kasahara M, Hashimoto R, Katsuura G, Mukoyama M et al (2000) Cardiac fibrosis in mice lacking brain natriuretic peptide. Proc Natl Acad Sci U S A 97:4239\u20134244","journal-title":"Proc Natl Acad Sci U S A"},{"key":"801_CR17","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1139\/y01-052","volume":"79","author":"Y Ogawa","year":"2001","unstructured":"Ogawa Y, Tamura N, Chusho H, Nakao K (2001) Brain natriuretic peptide appears to act locally as an antifibrotic factor in the heart. Can J Physiol Pharmacol 79:723\u2013729","journal-title":"Can J Physiol Pharmacol"},{"key":"801_CR18","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1161\/HYPERTENSIONAHA.110.163865","volume":"57","author":"AM Richards","year":"2011","unstructured":"Richards AM (2011) C-type natriuretic peptide and cardiac fibrosis. Hypertension 57:154\u2013155","journal-title":"Hypertension"},{"key":"801_CR19","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S0008-6363(01)00493-X","volume":"53","author":"OF Bueno","year":"2002","unstructured":"Bueno OF, van Rooij E, Molkentin JD, Doevendans PA, De Windt LJ (2002) Calcineurin and hypertrophic heart disease: novel insights and remaining questions. Cardiovasc Res 53:806\u2013821","journal-title":"Cardiovasc Res"},{"key":"801_CR20","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0092-8674(00)81573-1","volume":"93","author":"JD Molkentin","year":"1998","unstructured":"Molkentin JD, Lu JR, Antos CL, Markham B, Richardson J, Robbins J, Grant SR, Olson EN (1998) A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93:215\u2013228","journal-title":"Cell"},{"key":"801_CR21","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.cardiores.2004.01.021","volume":"63","author":"JD Molkentin","year":"2004","unstructured":"Molkentin JD (2004) Calcineurin\u2013NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs. Cardiovasc Res 63:467\u2013475","journal-title":"Cardiovasc Res"},{"key":"801_CR22","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1073\/pnas.041614798","volume":"98","author":"BA Rothermel","year":"2001","unstructured":"Rothermel BA, McKinsey TA, Vega RB, Nicol RL, Mammen P, Yang J, Antos CL, Shelton JM, Bassel-Duby R, Olson EN et al (2001) Myocyte-enriched calcineurin-interacting protein, MCIP1, inhibits cardiac hypertrophy in vivo. Proc Natl Acad Sci U S A 98:3328\u20133333","journal-title":"Proc Natl Acad Sci U S A"},{"key":"801_CR23","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S1050-1738(02)00188-3","volume":"13","author":"BA Rothermel","year":"2003","unstructured":"Rothermel BA, Vega RB, Williams RS (2003) The role of modulatory calcineurin-interacting proteins in calcineurin signaling. Trends Cardiovasc Med 13:15\u201321","journal-title":"Trends Cardiovasc Med"},{"key":"801_CR24","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1161\/01.CIR.99.3.441","volume":"99","author":"P Tamirisa","year":"1999","unstructured":"Tamirisa P, Blumer KJ, Muslin AJ (1999) RGS4 inhibits G-protein signaling in cardiomyocytes. Circulation 99:441\u2013447","journal-title":"Circulation"},{"key":"801_CR25","doi-asserted-by":"crossref","first-page":"7000","DOI":"10.1073\/pnas.1001825107","volume":"107","author":"X Wu","year":"2010","unstructured":"Wu X, Eder P, Chang B, Molkentin JD (2010) TRPC channels are necessary mediators of pathologic cardiac hypertrophy. Proc Natl Acad Sci U S A 107:7000\u20137005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"801_CR26","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nrm1983","volume":"7","author":"J Heineke","year":"2006","unstructured":"Heineke J, Molkentin JD (2006) Regulation of cardiac hypertrophy by intracellular signaling pathways. Nat Rev Mol Cell Biol 7:589\u2013600","journal-title":"Nat Rev Mol Cell Biol"},{"key":"801_CR27","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1161\/01.CIR.101.20.2431","volume":"101","author":"HW Lim","year":"2000","unstructured":"Lim HW, De Windt LJ, Steinberg L, Taigen T, Witt SA, Kimball TR, Molkentin JD (2000) Calcineurin expression, activation, and function in cardiac pressure-overload hypertrophy. Circulation 101:2431\u20132437","journal-title":"Circulation"},{"key":"801_CR28","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S0022-2828(03)00234-7","volume":"35","author":"T Saito","year":"2003","unstructured":"Saito T, Fukuzawa J, Osaki J, Sakuragi H, Yao N, Haneda T, Fujino T, Wakamiya N, Kikuchi K, Hasebe N (2003) Roles of calcineurin and calcium\/calmodulin-dependent protein kinase II in pressure overload-induced cardiac hypertrophy. J Mol Cell Cardiol 35:1153\u20131160","journal-title":"J Mol Cell Cardiol"},{"key":"801_CR29","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1161\/01.CIR.101.18.2134","volume":"101","author":"Y Eto","year":"2000","unstructured":"Eto Y, Yonekura K, Sonoda M, Arai N, Sata M, Sugiura S, Takenaka K, Gualberto A, Hixon ML, Wagner MW et al (2000) Calcineurin is activated in rat hearts with physiological left ventricular hypertrophy induced by voluntary exercise training. Circulation 101:2134\u20132137","journal-title":"Circulation"},{"key":"801_CR30","doi-asserted-by":"crossref","first-page":"3899","DOI":"10.1113\/jphysiol.2009.173948","volume":"587","author":"RS Oliveira","year":"2009","unstructured":"Oliveira RS, Ferreira JC, Gomes ER, Paix\u00e3o NA, Rolim NP, Medeiros A, Guatimosim S, Brum PC (2009) Cardiac anti-remodelling effect of aerobic training is associated with a reduction in the calcineurin\/NFAT signaling pathway in heart failure mice. J Physiol 587:3899\u20133910","journal-title":"J Physiol"},{"key":"801_CR31","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1161\/01.CIR.102.16.1996","volume":"102","author":"M Shimoyama","year":"2000","unstructured":"Shimoyama M, Hayashi D, Zou Y, Takimoto E, Mizukami M, Monzen K, Kudoh S, Hiroi Y, Yazaki Y, Nagai R et al (2000) Calcineurin inhibitor attenuates the development and induces the regression of cardiac hypertrophy in rats with salt-sensitive hypertension. Circulation 102:1996\u20132004","journal-title":"Circulation"},{"key":"801_CR32","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1161\/hc0602.104675","volume":"105","author":"Y Takeda","year":"2002","unstructured":"Takeda Y, Yoneda T, Demura M, Usukura M, Mabuchi H (2002) Calcineurin inhibition attenuates mineralocorticoid-induced cardiac hypertrophy. Circulation 105:677\u2013679","journal-title":"Circulation"},{"key":"801_CR33","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1161\/01.RES.0000109415.17511.18","volume":"94","author":"BJ Wilkins","year":"2004","unstructured":"Wilkins BJ, Dai YS, Bueno OF, Parsons SA, Xu J, Plank DM, Jones F, Kimball TR, Molkentin JD (2004) Calcineurin\/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy. Circ Res 94:110\u2013118","journal-title":"Circ Res"},{"key":"801_CR34","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1126\/science.281.5383.1690","volume":"281","author":"MA Sussman","year":"1998","unstructured":"Sussman MA, Lim HW, Gude N, Taigen T, Olson EN, Robbins J, Colbert MC, Gualberto A, Wieczorek DF, Molkentin JD (1998) Prevention of cardiac hypertrophy in mice by calcineurin inhibition. Science 281:1690\u20131693","journal-title":"Science"},{"key":"801_CR35","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1006\/jmcc.2000.1113","volume":"32","author":"HW Lim","year":"2000","unstructured":"Lim HW, De Windt LJ, Mante J, Kimball TR, Witt SA, Sussman MA, Molkentin JD (2000) Reversal of cardiac hypertrophy in transgenic disease models by calcineurin inhibition. J Mol Cell Cardiol 32:697\u2013709","journal-title":"J Mol Cell Cardiol"},{"key":"801_CR36","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1161\/CIRCULATIONAHA.104.510594","volume":"111","author":"T Tokudome","year":"2005","unstructured":"Tokudome T, Horio T, Kishimoto I, Soeki T, Mori K, Kawano Y, Kohno M, Garbers DL, Nakao K, Kangawa K (2005) Calcineurin-nuclear factor of activated T cells pathway-dependent cardiac remodeling in mice deficient in guanylyl cyclase A, a receptor for atrial and brain natriuretic peptides. Circulation 111:3095\u20133104","journal-title":"Circulation"},{"key":"801_CR37","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1161\/CIRCULATIONAHA.107.732990","volume":"117","author":"T Tokudome","year":"2008","unstructured":"Tokudome T, Kishimoto I, Horio T, Arai Y, Schwenke DO, Hino J, Okano I, Kawano Y, Kohno M, Miyazato M et al (2008) Regulator of G-protein signaling subtype 4 mediates antihypertrophic effect of locally secreted natriuretic peptides in the heart. Circulation 117:2329\u20132339","journal-title":"Circulation"},{"key":"801_CR38","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s00395-010-0098-z","volume":"105","author":"M Klaiber","year":"2010","unstructured":"Klaiber M, Kruse M, V\u00f6lker K, Schr\u00f6ter J, Feil R, Freichel M, Gerling A, Feil S, Dietrich A, Londo\u00f1o JE et al (2010) Novel insights into the mechanisms mediating the local antihypertrophic effects of cardiac atrial natriuretic peptide: role of cGMP-dependent protein kinase and RGS2. Basic Res Cardiol 105:583\u2013595","journal-title":"Basic Res Cardiol"},{"key":"801_CR39","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1161\/CIRCRESAHA.109.208314","volume":"106","author":"H Kinoshita","year":"2010","unstructured":"Kinoshita H, Kuwahara K, Nishida M, Jian Z, Rong X, Kiyonaka S, Kuwabara Y, Kurose H, Inoue R, Mori Y et al (2010) Inhibition of TRPC6 channel activity contributes to the antihypertrophic effects of natriuretic peptides-guanylyl cyclase-A signaling in the heart. Circ Res 106:1849\u20131860","journal-title":"Circ Res"},{"key":"801_CR40","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/cvr\/cvp208","volume":"84","author":"DJ Glenn","year":"2009","unstructured":"Glenn DJ, Rahmutula D, Nishimoto M, Liang F, Gardner DG (2009) Atrial natriuretic peptide suppresses endothelin gene expression and proliferation in cardiac fibroblasts through a GATA4-dependent mechanism. Cardiovasc Res 84:209\u2013217","journal-title":"Cardiovasc Res"},{"key":"801_CR41","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/cvr\/cvp297","volume":"84","author":"M Jankowski","year":"2009","unstructured":"Jankowski M (2009) GATA4, a new regulator of cardiac fibroblasts, is sensitive to natriuretic peptides. Cardiovasc Res 84:176\u2013177","journal-title":"Cardiovasc Res"},{"key":"801_CR42","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.yjmcc.2008.01.005","volume":"44","author":"M Karmazyn","year":"2008","unstructured":"Karmazyn M, Kili\u0107 A, Javadov S (2008) The role of NHE-1 in myocardial hypertrophy and remodelling. J Mol Cell Cardiol 44:647\u2013653","journal-title":"J Mol Cell Cardiol"},{"key":"801_CR43","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1161\/CIRCULATIONAHA.106.626929","volume":"115","author":"HE Cingolani","year":"2007","unstructured":"Cingolani HE, Ennis IL (2007) Sodium-hydrogen exchanger, cardiac overload, and myocardial hypertrophy. Circulation 115:1090\u20131100","journal-title":"Circulation"},{"key":"801_CR44","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1161\/01.RES.75.2.369","volume":"75","author":"N Khandoudi","year":"1994","unstructured":"Khandoudi N, Ho J, Karmazyn M (1994) Role of Na(+)-H\u2009+\u2009exchange in mediating effects of endothelin-1 on normal and ischemic\/reperfused hearts. Circ Res 75:369\u2013378","journal-title":"Circ Res"},{"key":"801_CR45","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1172\/JCI119123","volume":"99","author":"N Ito","year":"1997","unstructured":"Ito N, Kagaya Y, Weinberg EO, Barry WH, Lorell BH (1997) Endothelin and angiotensin II stimulation of Na\u2009+\u2009\u2212H\u2009+\u2009exchange is impaired in cardiac hypertrophy. J Clin Invest 99:125\u2013135","journal-title":"J Clin Invest"},{"key":"801_CR46","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S0008-6363(99)00210-2","volume":"44","author":"HE Cingolani","year":"1999","unstructured":"Cingolani HE (1999) Na+\/H\u2009+\u2009exchange hyperactivity and myocardial hypertrophy: are they linked phenomena? Cardiovasc Res 44:462\u2013467","journal-title":"Cardiovasc Res"},{"key":"801_CR47","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/MNH.0b013e3282f56854","volume":"17","author":"MJ Young","year":"2008","unstructured":"Young MJ (2008) Mechanisms of mineralocorticoid receptor-mediated cardiac fibrosis and vascular inflammation. Curr Opin Nephrol Hypertens 17:174\u2013180","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"801_CR48","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S0008-6363(02)00809-X","volume":"57","author":"A Baartscheer","year":"2003","unstructured":"Baartscheer A, Schumacher CA, van Borren MM, Belterman CN, Coronel R, Fiolet JW (2003) Increased Na+\/H\u2009+\u2009\u2212exchange activity is the cause of increased [Na+]i and underlies disturbed calcium handling in the rabbit pressure and volume overload heart failure model. Cardiovasc Res 57:1015\u20131024","journal-title":"Cardiovasc Res"},{"key":"801_CR49","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1038\/bjp.2008.189","volume":"154","author":"A Baartscheer","year":"2008","unstructured":"Baartscheer A, Hardziyenka M, Schumacher CA, Belterman CN, van Borren MM, Verkerk AO, Coronel R, Fiolet JW (2008) Chronic inhibition of the Na+\/H+-exchanger causes regression of hypertrophy, heart failure, and ionic and electrophysiological remodeling. Br J Pharmacol 154:1266\u20131275","journal-title":"Br J Pharmacol"},{"key":"801_CR50","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cardiores.2004.09.024","volume":"65","author":"A Baartscheer","year":"2005","unstructured":"Baartscheer A, Schumacher CA, van Borren MM, Belterman CN, Coronel R, Opthof T, Fiolet JW (2005) Chronic inhibition of Na+\/H+-exchanger attenuates cardiac hypertrophy and prevents cellular remodeling in heart failure. Cardiovasc Res 65:83\u201392","journal-title":"Cardiovasc Res"},{"key":"801_CR51","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1161\/HYPERTENSIONAHA.107.087759","volume":"49","author":"NG P\u00e9rez","year":"2007","unstructured":"P\u00e9rez NG, Piaggio MR, Ennis IL, Garciarena CD, Morales C, Escudero EM, Cingolani OH, Chiappe de Cingolani G, Yang XP, Cingolani HE (2007) Phosphodiesterase 5A inhibition induces Na+\/H\u2009+\u2009exchanger blockade and protection against myocardial infarction. Hypertension 49:1095\u20131103","journal-title":"Hypertension"},{"key":"801_CR52","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1161\/01.RES.83.8.870","volume":"83","author":"DE Dostal","year":"1998","unstructured":"Dostal DE, Baker KM (1998) Angiotensin and endothelin: messengers that couple ventricular stretch to the Na+\/H\u2009+\u2009exchanger and cardiac hypertrophy. Circ Res 83:870\u2013873","journal-title":"Circ Res"},{"key":"801_CR53","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1161\/CIRCULATIONAHA.105.542209","volume":"112","author":"A Kilic","year":"2005","unstructured":"Kilic A, Velic A, De Windt LJ, Fabritz L, Voss M, Mitko D, Zwiener M, Baba HA, van Eickels M, Schlatter E et al (2005) Enhanced activity of the myocardial Na+\/H\u2009+\u2009exchanger NHE-1 contributes to cardiac remodeling in atrial natriuretic peptide receptor-deficient mice. Circulation 112:2307\u20132317","journal-title":"Circulation"},{"key":"801_CR54","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/cvr\/cvq254","volume":"88","author":"A Kilic","year":"2010","unstructured":"Kilic A, Rajapurohitam V, Sandberg SM, Zeidan A, Hunter JC, Said Faruq N, Lee CY, Burnett JC Jr, Karmazyn M (2010) A novel chimeric natriuretic peptide reduces cardiomyocyte hypertrophy through the NHE-1-calcineurin pathway. Cardiovasc Res 88:434\u2013442","journal-title":"Cardiovasc Res"},{"key":"801_CR55","doi-asserted-by":"crossref","unstructured":"Dobaczewski M, Chen W, Frangogiannis NG (2011) Transforming growth factor (TGF)-\u03b2 signaling in cardiac remodeling. J Mol Cell Cardiol","DOI":"10.1016\/j.yjmcc.2010.10.033"},{"key":"801_CR56","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.cardiores.2004.04.030","volume":"63","author":"S Rosenkranz","year":"2004","unstructured":"Rosenkranz S (2004) TGF-beta1 and angiotensin networking in cardiac remodeling. Cardiovasc Res 63:423\u2013432","journal-title":"Cardiovasc Res"},{"key":"801_CR57","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.cardiores.2006.10.002","volume":"74","author":"M Bujak","year":"2007","unstructured":"Bujak M, Frangogiannis NG (2007) The role of TGF-beta signaling in myocardial infarction and cardiac remodeling. Cardiovasc Res 74:184\u2013195","journal-title":"Cardiovasc Res"},{"key":"801_CR58","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.2147\/VHRM.S3985","volume":"4","author":"R Ramos-Mondrag\u00f3n","year":"2008","unstructured":"Ramos-Mondrag\u00f3n R, Galindo CA, Avila G (2008) Role of TGF-beta on cardiac structural and electrical remodeling. Vasc Health Risk Manag 4:1289\u20131300","journal-title":"Vasc Health Risk Manag"},{"key":"801_CR59","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1096\/fj.03-1273rev","volume":"18","author":"A Leask","year":"2004","unstructured":"Leask A, Abraham DJ (2004) TGF-beta signaling and the fibrotic response. FASEB J 18:816\u2013827","journal-title":"FASEB J"},{"key":"801_CR60","doi-asserted-by":"crossref","first-page":"H1282","DOI":"10.1152\/ajpheart.00910.2006","volume":"293","author":"B Wang","year":"2007","unstructured":"Wang B, Omar A, Angelovska T, Drobic V, Rattan SG, Jones SC, Dixon IM (2007) Regulation of collagen synthesis by inhibitory Smad7 in cardiac myofibroblasts. Am J Physiol Heart Circ Physiol 293:H1282\u2013H1290","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"801_CR61","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1161\/01.CIR.0000020689.12472.E0","volume":"106","author":"F Kuwahara","year":"2002","unstructured":"Kuwahara F, Kai H, Tokuda K, Kai M, Takeshita A, Egashira K, Imaizumi T (2002) Transforming growth factor-beta function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats. Circulation 106:130\u2013135","journal-title":"Circulation"},{"key":"801_CR62","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1161\/01.CIR.0000051865.66123.B7","volume":"107","author":"S Hein","year":"2003","unstructured":"Hein S, Arnon E, Kostin S, Sch\u00f6nburg M, Els\u00e4sser A, Polyakova V, Bauer EP, Kl\u00f6vekorn WP, Schaper J (2003) Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms. Circulation 107:984\u2013991","journal-title":"Circulation"},{"key":"801_CR63","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.lfs.2006.03.051","volume":"79","author":"YF Chen","year":"2006","unstructured":"Chen YF, Feng JA, Li P, Xing D, Ambalavanan N, Oparil S (2006) Atrial natriuretic peptide-dependent modulation of hypoxia-induced pulmonary vascular remodeling. Life Sci 79:1357\u20131365","journal-title":"Life Sci"},{"key":"801_CR64","doi-asserted-by":"crossref","first-page":"H1253","DOI":"10.1152\/ajpheart.00578.2001","volume":"283","author":"S Rosenkranz","year":"2002","unstructured":"Rosenkranz S, Flesch M, Amann K, Haeuseler C, Kilter H, Seeland U, Schluter K-D, Bohm M (2002) Alterations of \u03b2-adrenergic signaling and cardiac hypertrophy in transgenic mice overexpressing TGF-\u03b21. Am J Physiol Heart 283:H1253\u2013H1262","journal-title":"Am J Physiol Heart"},{"key":"801_CR65","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1006\/jmcc.1999.1065","volume":"32","author":"WW Brooks","year":"2000","unstructured":"Brooks WW, Conrad CH (2000) Myocardial fibrosis in transforming growth factor beta (1) heterozygous mice. J Mol Cell Cardiol 32:187\u2013195","journal-title":"J Mol Cell Cardiol"},{"key":"801_CR66","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1172\/JCI42028","volume":"120","author":"P Teekakirikul","year":"2010","unstructured":"Teekakirikul P, Eminaga S, Toka O, Alcalai R, Wang L, Wakimoto H, Nayor M, Konno T, Gorham JM, Wolf CM et al (2010) Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-\u03b2. J Clin Invest 120:3520\u20133529","journal-title":"J Clin Invest"},{"key":"801_CR67","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1161\/01.CIR.96.3.874","volume":"96","author":"RK Li","year":"1997","unstructured":"Li RK, Li G, Mickle DA, Weisel RD, Merante F, Luss H, Rao V, Christakis GT, Williams WG (1997) Overexpression of transforming growth factor-beta1 and insulin-like growth factor-1 in patients with idiopathic hypertrophic cardiomyopathy. Circulation 96:874\u2013881","journal-title":"Circulation"},{"key":"801_CR68","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1136\/heart.86.6.701","volume":"86","author":"JE Sanderson","year":"2001","unstructured":"Sanderson JE, Lai KB, Shum IO, Wei S, Chow LT (2001) Transforming growth factor-beta(1) expression in dilated cardiomyopathy. Heart 86:701\u2013708","journal-title":"Heart"},{"key":"801_CR69","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1007\/s00018-006-6085-8","volume":"63","author":"H Lim","year":"2006","unstructured":"Lim H, Zhu YZ (2006) Role of transforming growth factor-beta in the progression of heart failure. Cell Mol Life Sci 63:2584\u20132596","journal-title":"Cell Mol Life Sci"},{"key":"801_CR70","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1161\/CIRCRESAHA.107.157677","volume":"102","author":"P Li","year":"2008","unstructured":"Li P, Wang D, Lucas J, Oparil S, Xing D, Cao X, Novak L, Renfrow MB, Chen YF (2008) Atrial natriuretic peptide inhibits transforming growth factor beta-induced Smad signaling and myofibroblast transformation in mouse cardiac fibroblasts. Circ Res 102:185\u2013192","journal-title":"Circ Res"},{"key":"801_CR71","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1161\/CIRCRESAHA.107.170217","volume":"102","author":"IL Buxton","year":"2008","unstructured":"Buxton IL, Duan D (2008) Cyclic GMP\/protein kinase G phosphorylation of Smad3 blocks transforming growth factor-beta-induced nuclear Smad translocation: a key antifibrogenic mechanism of atrial natriuretic peptide. Circ Res 102:151\u2013153","journal-title":"Circ Res"},{"key":"801_CR72","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1440-1681.2009.05281.x","volume":"37","author":"JG He","year":"2010","unstructured":"He JG, Chen YL, Chen BL, Huang YY, Yao FJ, Chen SL, Dong YG (2010) B-type natriuretic peptide attenuates cardiac hypertrophy via the transforming growth factor-\u00df1\/smad7 pathway in vivo and in vitro. Clin Exp Pharmacol Physiol 37:283\u2013289","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"801_CR73","first-page":"H1318","volume":"263","author":"AJ Stingo","year":"1992","unstructured":"Stingo AJ, Clavell AL, Heiblein DM, Wei CM, Pittelkow MR, Burnett JC Jr (1992) Presence of C-type natriuretic peptide in cultured human endothelial cells and plasma. Am J Physiol 263:H1318\u2013H1321","journal-title":"Am J Physiol"},{"key":"801_CR74","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1161\/01.HYP.37.4.1179","volume":"37","author":"ML Honing","year":"2001","unstructured":"Honing ML, Smits P, Morrison PJ, Burnett JC Jr, Rabelink TJ (2001) C-type natriuretic peptide-induced vasodilation is dependent on hyperpolarization in human forearm resistance vessels. Hypertension 37:1179\u20131183","journal-title":"Hypertension"},{"key":"801_CR75","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0008-6363(97)00086-2","volume":"35","author":"HG Hutchinson","year":"1997","unstructured":"Hutchinson HG, Trindade PT, Cunanan DB, Wu CF, Pratt RE (1997) Mechanisms of natriuretic peptide-induced growth inhibition of vascular smooth muscle cells. Cardiovasc Res 35:158\u2013167","journal-title":"Cardiovasc Res"},{"key":"801_CR76","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1749-6632.1994.tb17352.x","volume":"748","author":"M Furuya","year":"1995","unstructured":"Furuya M, Miyazaki T, Honbou N, Kawashima K, Ohno T, Tanaka S, Kangawa K, Matsuo H (1995) C-type natriuretic peptide inhibits intimal thickening after vascular injury. Ann NY Acad Sci 748:517\u2013523","journal-title":"Ann NY Acad Sci"},{"key":"801_CR77","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1210\/en.2003-1260","volume":"145","author":"T Tokudome","year":"2004","unstructured":"Tokudome T, Horio T, Soeki T, Mori K, Kishimoto I, Suga S, Yoshihara F, Kawano Y, Kohno M, Kangawa K (2004) Inhibitory effect of C-type natriuretic peptide (CNP) on cultured cardiac myocyte hypertrophy: interference between CNP and endothelin-1 signaling pathways. Endocrinology 145:2131\u20132140","journal-title":"Endocrinology"},{"key":"801_CR78","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.jacc.2004.10.067","volume":"45","author":"T Soeki","year":"2005","unstructured":"Soeki T, Kishimoto I, Okumura H, Tokudome T, Horio T, Mori K, Kangawa K (2005) C-type natriuretic peptide, a novel antifibrotic and antihypertrophic agent, prevents cardiac remodeling after myocardial infarction. J Am Coll Cardiol 45:608\u2013616","journal-title":"J Am Coll Cardiol"},{"key":"801_CR79","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1210\/en.2003-0128","volume":"144","author":"T Horio","year":"2003","unstructured":"Horio T, Tokudome T, Maki T, Yoshihara F, Suga S, Nishikimi T, Kojima M, Kawano Y, Kangawa K (2003) Gene expression, secretion, and autocrine action of C-type natriuretic peptide in cultured adult rat cardiac fibroblasts. Endocrinology 144:2279\u20132284","journal-title":"Endocrinology"},{"key":"801_CR80","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1016\/j.peptides.2008.09.005","volume":"29","author":"S Ry Del","year":"2008","unstructured":"Del Ry S, Cabiati M, Lionetti V, Emdin M, Recchia FA, Giannessi D (2008) Expression of C-type natriureitc peptide and of its receptor NPR-B in normal and failing heart. Peptides 29:2208\u20132215","journal-title":"Peptides"},{"key":"801_CR81","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1161\/01.CIR.0000047280.15244.EB","volume":"107","author":"PR Kalra","year":"2003","unstructured":"Kalra PR, Clague JR, Bolger AP, Anker SD, PooleWilson PA, Struthers AD, Coats AJ (2003) Myocardial production of C-type natriuretic peptide in chronic heart failure. Circulation 107:571\u2013573","journal-title":"Circulation"},{"key":"801_CR82","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1210\/en.2007-0081","volume":"148","author":"DM Dickey","year":"2007","unstructured":"Dickey DM, Flora DR, Bryan PM, Xu X, Chen Y, Potter LR (2007) Differential regulation of membrane guanylyl cyclases in congestive heart failure: natriuretic peptide receptor (NPR)-B, not NPR-A, is the predominant natriureitc peptide receptor in the failing heart. Endocrinology 148:3518\u20133522","journal-title":"Endocrinology"},{"key":"801_CR83","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s00109-007-0183-4","volume":"85","author":"I Pagel-Langenickel","year":"2007","unstructured":"Pagel-Langenickel I, Buttgereit J, Bader M, Langenickel TH (2007) Natriuretic peptide receptor B signaling in the cardiovascular system: protection from cardiac hypertrophy. J Mol Med 85:797\u2013810","journal-title":"J Mol Med"},{"key":"801_CR84","doi-asserted-by":"crossref","first-page":"4735","DOI":"10.1073\/pnas.0510019103","volume":"103","author":"TH Langenickel","year":"2006","unstructured":"Langenickel TH, Buttgereit J, Pagel-Langenickel I, Lindner M, Monti J, Beuerlein K, Al-Saadi N, Plehm R, Popova E, Tank J et al (2006) Cardiac hypertrophy in transgenic rats expressing a dominant-negative mutant of the natriuretic peptide receptor B. Proc Natl Acad Sci U S A 103:4735\u20134740","journal-title":"Proc Natl Acad Sci U S A"},{"key":"801_CR85","doi-asserted-by":"crossref","first-page":"H2318","DOI":"10.1152\/ajpheart.2001.281.6.H2318","volume":"281","author":"N Herring","year":"2001","unstructured":"Herring N, Zamman JA, Paterson DJ (2001) Natriuretic peptides like NO facilitate cardiac vagal neurotransmission and bradycardia via a cGMP pathway. Am J Physiol Heart Circ Physiol 281:H2318\u2013H2327","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"801_CR86","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1161\/HYPERTENSIONAHA.110.160796","volume":"57","author":"SJ Sangaralingham","year":"2011","unstructured":"Sangaralingham SJ, Huntley BK, Martin FL, McKie PM, Bellavia D, Ichiki T, Harders GE, Chen HH, Burnett JC Jr (2011) The aging heart, myocardial fibrosis, and its relationship to circulating C-type natriuretic peptide. Hypertension 57:201\u2013207","journal-title":"Hypertension"},{"key":"801_CR87","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s00109-010-0641-2","volume":"88","author":"S Rubattu","year":"2010","unstructured":"Rubattu S, Sciarretta S, Morriello A, Calvieri C, Battistoni A, Volpe M (2010) NPR-C: a component of the natriuretic peptide family with implications in human diseases. J Mol Med 88:889\u2013897","journal-title":"J Mol Med"},{"key":"801_CR88","doi-asserted-by":"crossref","first-page":"7403","DOI":"10.1073\/pnas.96.13.7403","volume":"96","author":"N Matsukawa","year":"1999","unstructured":"Matsukawa N, Grzesik WJ, Takahashi N, Pandey KN, Pang S, Yamauchi M, Smithies O (1999) The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system. Proc Natl Acad Sci U S A 96:7403\u20137408","journal-title":"Proc Natl Acad Sci U S A"},{"key":"801_CR89","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1073\/pnas.0336365100","volume":"100","author":"SD Chauhan","year":"2003","unstructured":"Chauhan SD, Nilsson H, Ahluwalia A, Hobbs AJ (2003) Release of C-type natriuretic peptide accounts for the biological activity of endothelium-derived hyperpolarizing factor. Proc Natl Aca Sci U S A 100:1426\u20131431","journal-title":"Proc Natl Aca Sci U S A"},{"key":"801_CR90","doi-asserted-by":"crossref","first-page":"H2454","DOI":"10.1152\/ajpheart.00388.2003","volume":"285","author":"RA Rose","year":"2003","unstructured":"Rose RA, Lomax AE, Giles WR (2003) Inhibition of L-type Ca2+ current by C-type natriuretic peptide in bullfrog atrial myocytes: an NPR-C-mediated effect. Am J Physiol Heart Circ Physiol 285:H2454\u2013H2462","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"57","key":"801_CR91","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1016\/j.jacc.2010.12.032","volume":"31","author":"YT Horikawa","year":"2011","unstructured":"Horikawa YT, Panneerselvam M, Kawaraguchi Y, Tsutsumi YM, Ali SS, Balijepalli RC, Murray F, Head BP, Niesman IR, Rieg T et al (2011) Cardiac-specific overexpression of caveolin-3 attenuates cardiac hypertrophy and increases natriuretic peptide expression and signaling. J Am Coll Cardiol 31(57):2273\u20132283","journal-title":"J Am Coll Cardiol"},{"key":"801_CR92","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1161\/CIRCULATIONAHA.110.981720","volume":"123","author":"A Cataliotti","year":"2011","unstructured":"Cataliotti A, Tonne JM, Bellavia D, Martin FL, Oehler EA, Harders GE, Campbell JM, Peng KW, Russell SJ, Malatino LS et al (2011) Long-term cardiac pro-B-type natriuretic peptide gene delivery prevents the development of hypertensive heart disease in spontaneously hypertensive rats. Circulation 123:1297\u20131305","journal-title":"Circulation"},{"key":"801_CR93","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1016\/S0735-1097(01)01233-5","volume":"37","author":"M Hayashi","year":"2001","unstructured":"Hayashi M, Tsutamoto T, Wada A, Maeda K, Mabuchi N, Tsutsui T, Horie H, Ohnishi M, Kinoshita M (2001) Intravenous atrial natriuretic peptide prevents left ventricular remodeling in patients with first anterior acute myocardial infarction. J Am Coll Cardiol 37:1820\u20131826","journal-title":"J Am Coll Cardiol"},{"key":"801_CR94","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1253\/circj.71.1401","volume":"71","author":"A Sezai","year":"2007","unstructured":"Sezai A, Hata M, Wakui S, Niino T, Takayama T, Hirayama A, Saito S, Minami K (2007) Efficacy of continuous low-dose hANP administration in patients undergoing emergent coronary artery bypass grafting for acute coronary syndrome. Circ J 71:1401\u20131407","journal-title":"Circ J"},{"key":"801_CR95","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1136\/hrt.2006.110239","volume":"94","author":"RJ Hillock","year":"2008","unstructured":"Hillock RJ, Frampton CM, Yandle TG, Troughton RW, Lainchbury JG, Richards AM (2008) B-type natriuretic peptide infusions in acute myocardial infarction. Heart 94:617\u2013622","journal-title":"Heart"},{"key":"801_CR96","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/S0140-6736(07)61634-1","volume":"370","author":"M Kitakaze","year":"2007","unstructured":"Kitakaze M, Asakura M, Kim J, Shintani Y, Asanuma H, Hamasaki T, Seguchi O, Myoishi M, Minamino T, Ohara T et al (2007) Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomized trials. Lancet 370:1483\u20131493","journal-title":"Lancet"},{"key":"801_CR97","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1253\/circj.CJ-08-0130","volume":"72","author":"N Hata","year":"2008","unstructured":"Hata N, Seino Y, Tsutamoto T, Hiramitsu S, Kaneko N, Yoshikawa T, Yokoyama H, Tanaka K, Mizuno K, Nejima J et al (2008) Effects of carperitide on the long-term prognosis of patients with acute decompensated chronic heart failure\u2014the PROTECT multicenter randomized controlled study. Circ J 72:1787\u20131793","journal-title":"Circ J"},{"key":"801_CR98","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jacc.2005.03.051","volume":"46","author":"WT Abraham","year":"2005","unstructured":"Abraham WT, Adams KF, Fonarow GC, Costanzo MR, Berkowitz RL, LeJemtel TH, Cheng ML, Wynne J (2005) In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications. An analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). J Am Coll Cardiol 46:57\u201364","journal-title":"J Am Coll Cardiol"},{"key":"801_CR99","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0140-6736(00)02602-7","volume":"356","author":"JL Rouleau","year":"2000","unstructured":"Rouleau JL, Pfeffer MA, Stewart DJ, Isaac D, Sestier F, Kerut EK, Porter CB, Proulx G, Qian C, Block AJ (2000) Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomized trial. Lancet 356:615\u2013620","journal-title":"Lancet"},{"key":"801_CR100","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1517\/13543784.2011.556617","volume":"20","author":"F Cuculi","year":"2011","unstructured":"Cuculi F, Erne P (2011) Combined neutral endopeptidases inhibitors. Expert Opin Invest Drugs 20:457\u2013463","journal-title":"Expert Opin Invest Drugs"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-011-0801-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00109-011-0801-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-011-0801-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T22:17:44Z","timestamp":1560464264000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00109-011-0801-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,9]]},"references-count":100,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["801"],"URL":"https:\/\/doi.org\/10.1007\/s00109-011-0801-z","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,9]]}}}